Effect of a modified goal-directed fluid therapy on postoperative complications in patients undergoing brain tumor surgery
Not Applicable
- Conditions
- Neoplasms
- Registration Number
- KCT0009241
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 210
Inclusion Criteria
Adult patients 18 years of age or older undergoing brain tumor removal under general anesthesia
Exclusion Criteria
Patients who do not agree to the study
Patients with severe cardiopulmonary or renal disease
Patients who are unable to give informed consent due to a decreased level of consciousness
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method composite postoperative complication
- Secondary Outcome Measures
Name Time Method pH, lactate, paCO2, PaO2/FiO2, Hct, BUN, creatinine, eGFR, bilirubin, AST, ALT;Invasive systolic/diastolic arterial pressure, mean arterial pressure, pulse rate, invasive central venous pressure, cardiac output, cardiac index, stroke volume variation, stroke volume index, peripheral oxygen saturation;Hypotensiove episode count, duration;Ephedrine, phenylephrine, norepinephrine, propofol, remifentanil dose, infused plasma solution A amount, infused pRBC amount, estimated blood loss, urine output;neurologic monitoring abnormalities;neuron-specific enolase;anesthesia time, surgery time;in hospital mortality;Total length of stay, ICU length of stay;Time to extubation;Time to recovery of bowel function;Modified Rankin Scale